Your browser doesn't support javascript.
loading
Polybacterial aetiology and outcomes in patients with community-acquired pneumonia.
Kumagai, S; Ishida, T; Tachibana, H; Ito, A; Ito, Y; Hashimoto, T.
Affiliation
  • Kumagai S; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ishida T; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
  • Tachibana H; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ito A; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ito Y; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
  • Hashimoto T; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Japan.
Int J Tuberc Lung Dis ; 20(1): 129-35, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26688539
ABSTRACT

SETTING:

Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality worldwide. While interactions among bacterial pathogens in the respiratory tract have been studied, the impact of polybacterial aetiology on mortality has not been fully elucidated.

OBJECTIVE:

To investigate the impact of polybacterial aetiology on mortality, prevalence, microbial patterns and clinical characteristics among CAP patients.

DESIGN:

Retrospective data analysis.

RESULTS:

Bacterial aetiology was established in 711 (46.0%) of 1544 enrolled hospitalised CAP patients. Of these, polybacterial aetiology was identified in 89 (12.5%) Streptococcus pneumoniae was the most frequently identified pathogen (n = 55, 61.8%). The most prevalent microbial combination was S. pneumoniae and Haemophilus influenzae (n = 19, 21.3%). Alcoholism and lack of previous antibiotic therapy were independent predictors of polybacterial aetiology. The proportion of patients with severe pneumonia was significantly higher in the polybacterial aetiology group than in the monobacterial group. Multivariate analysis showed that polybacterial aetiology was a predictor of 30-day mortality (OR 2.14, 95%CI 1.07-4.24, P = 0.030), independently of severe pneumonia status, pneumonia severity index, chronic obstructive pulmonary disease and inappropriate empirical therapy.

CONCLUSION:

Polybacterial CAP tends to advance in severity, and indicates adverse outcomes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Community-Acquired Infections / Pneumonia, Bacterial Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2016 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Community-Acquired Infections / Pneumonia, Bacterial Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int J Tuberc Lung Dis Year: 2016 Document type: Article Affiliation country: Japan